Pfizer grapples with ‘a world of hurt’ after Covid triumph

Pfizer is grappling with 'a world of hurt' following its Covid triumph. The company faces mounting pressure due to sliding vaccine revenues and fears that it overpaid for new drugs. This combination of financial issues puts significant stress on boss Albert Bourla.